Constraints on publication rights in industry-initiated clinical trials

被引：54

作者：

Gotzsche, PC ^{[1
]}

Hróbjartsson, A

Johansen, HK

Haahr, MT

Altman, DG

Chan, AW

机构：

[1] Nord Cochrane Ctr, Copenhagen, Denmark

[2] Ctr Stat Med, Oxford, England

[3] Univ Toronto, Dept Med, Toronto, ON, Canada

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2006年 / 295卷 / 14期

关键词：

D O I：

10.1001/jama.295.14.1645

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1645 / 1646

页数：2

共 4 条

[1] Empirical evidence for selective reporting of outcomes in randomized trials -: Comparison of Protocols to published articles [J].

Chan, AW ;

Hróbjartsson, A ;

Haahr, MT ;

Gotzsche, PC ;

Altman, DG .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 291 (20) :2457-2465

[2] Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1) [J].

Krleza-Jeric, K ;

Chan, AW ;

Dickersin, K ;

Sim, I ;

Grimshaw, J ;

Gluud, C .

BMJ-BRITISH MEDICAL JOURNAL, 2005, 330 (7497) :956-958

[3] Academic medical centers' standards for clinical-trial agreements with industry [J].

Mello, MM ;

Clarridge, BR ;

Studdert, DM .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (21) :2202-2210

[4] A national survey of provisions in clinical-trial agreements between medical schools and industry sponsors [J].

Schulman, KA ;

Seils, DM ;

Timbie, JW ;

Sugarman, J ;

Dame, LA ;

Weinfurt, KP ;

Mark, DB ;

Califf, RM .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (17) :1335-1341

← 1 →